Cannalytics Research Center (CRC) we are a regulatory, compliance, scientific testing and analytical firm, with our focus in the cannabis industry. We are building a Cannabis Compliance/Regulatory Laboratory Testing Infrastructure starting with our flagship testing and research facility in Branchburg, NJ. To achieve profitable operations Cannalytics has selected 4 additional locations for our Phase 1 Build out. These key markets are in dire need of additional testing laboratories, as there is a high demand and low supply for laboratory testing services. Rapid national expansion is planned in existing key markets along with future markets as legalization develops.
Cannalytics provides patients, cultivators, producers and dispensaries with valuable certified information about the safety, quality and potency of their medical/recreational cannabis products. Cannalytics has begun its operations in Lafayette, NJ 07848 corporate office with its primary DEA & FDA licensed laboratory and research center located in Branchburg, NJ 08876 in our 5,500 square feet, well-equipped biomedical testing laboratory.
Cannalytics intends to provide a comprehensive menu of services to stakeholders in the medical/recreational cannabis industry. These services will include cannabinoid profiling, microbiological screening, pesticide screening, terpene analysis, infused-product formulation charts and more, Cannalytics offers tests and services aimed to guarantee the quality and potency of all medical cannabis products. We look to establish long-lasting relationships with our clients through accurate data, quick turnaround and exemplary services.
Cannalytics Research Center has identified multiple problems within the cannabis testing industry, starting with regulation and compliance. Regulations are currently being developed on a state to state basis but there is no national standard or guideline for independent testing facilities. Cannalytics is approaching the market on a national level with international enterprise solutions.
One of the biggest areas of concern for cultivators, producers, dispensaries, and most importantly consumers is fraudulent or inaccurate testing results which has been identified in multiple states where cannabis has been legalized on a state level. Through our strategic partnerships with enterprise software developers and analytical testing equipment manufacturers, we have developed a comprehensive platform to identify and potentially eliminate fraudulent or inaccurate results which include false potency reporting.
Cannalytics visions became reality.February, 2018